23andMe and its customers’ genetic data bought by a pharmaceutical org

Security Update News

Update Information

Title 23andMe and its customers’ genetic data bought by a pharmaceutical org
Update ID MALWAREBYTES:BA35C01447AA935C266AD599FF2A0AA6
Type malwarebytes
Published 2025-05-20T12:29:05
Last Updated 2025-05-20T12:29:05

Security Impact

CVSS Score 0.0
Severity NONE
Attack Vector

Affected CVEs

Update Details

The bankrupt genetic testing company 23andMe has been acquired by Regeneron Pharmaceuticals, raising concerns about the privacy and security of genetic data. Customers are advised to manage their data settings to protect their information.

View Advisory Details

💭 Join the Security Discussion

🔒 Your email address will not be published. Required fields are marked *

⚠️ Please be respectful and constructive in your comments. Security discussions should remain professional.